Angiodynamics earnings were -$36.7M for the trailing 12 months ending May 31, 2026, with N/A growth year over year. The latest ANGO earnings report on May 31, 2026 announced Q2 2026 earnings of -$11.4M, up 41.1% from last quarter. For the last reported fiscal year 2026 ending May 31, 2026, ANGO reported annual earnings of -$36.7M, with 8.1% growth. The next ANGO earnings date is Oct 1, 2026.
On ANGO's earnings call on Jul 14, 2026, Angiodynamics (NASDAQ: ANGO) reported Q2 2026 earnings per share (EPS) of -$0.27, up 80% year over year. Total ANGO earnings for the quarter were -$11.41 million. In the same quarter last year, Angiodynamics's earnings per share (EPS) was -$0.15.
The next ANGO earnings call is Oct 1, 2026. Add ANGO to your watchlist to be reminded of Angiodynamics's next earnings date.
Is Angiodynamics profitable or losing money?
As of the last Angiodynamics earnings report, Angiodynamics is currently losing money. Angiodynamics's net profit (also called net income) for the twelve months ending May 31, 2026 was -$36.74 million, a 8.09% increase year over year.
What was ANGO's earnings growth in the past year?
As of Angiodynamics's earnings date in Jul 14, 2026, Angiodynamics's earnings has grown year over year. ANGO earnings in the past year totalled -$36.74 million.
What are Angiodynamics's earnings expectations?
The current EPS estimate for Angiodynamics's earnings report in Oct 1, 2026 is -$0.11.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.